Due to the high somatic rate of BAP1 variants, it was felt that reflex BAP1 germline testing was not appropriate and the decision to proceed to germline testing should only be undertaken in the context of a BAP1-associated tumour with additional supportive information e.g., IHC loss, age of onset and personal /family history. This evidence concerns the gene BAP1 and neoplasm.